Clinical and Emergent Biomarkers and Their Relationship to the Prognosis of Ovarian Cancer | Zendy

Aminah Jatoi | Zendy; Robert A. Vierkant | Zendy; Kieran Hawthorne | Zendy; Matthew S. Block | Zendy; Susan J. Ramus | Zendy; Nicholas B. Larson | Zendy; Brooke L. Fridley | Zendy; Ellen L. Goode | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Clinical and Emergent Biomarkers and Their Relationship to the Prognosis of Ovarian Cancer

Author(s) -

Aminah Jatoi,

Robert A. Vierkant,

Kieran Hawthorne,

Matthew S. Block,

Susan J. Ramus,

Nicholas B. Larson,

Brooke L. Fridley,

Ellen L. Goode

Publication year - 2016

Publication title -

oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.987

H-Index - 98

eISSN - 1423-0232

pISSN - 0030-2414

DOI - 10.1159/000442710

Subject(s) - medicine , hazard ratio , ovarian cancer , oncology , malignancy , cancer , ascites , multivariate analysis , univariate analysis , confidence interval , proportional hazards model , prognostic variable , cohort , stage (stratigraphy) , gastroenterology , biology , paleontology

Ovarian cancer is the most lethal gynecological malignancy, but information relevant to prognosis and outcomes remain unknown. Here, we used statistical methods to focus specifically on interactions between candidate prognostic variables.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research